Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice

被引:116
作者
Fukutake, M
Nakatsugi, S
Isoi, T
Takahashi, M
Ohta, T
Mamiya, S
Taniguchi, Y
Sato, H
Fukuda, K
Sugimura, T
Wakabayashi, K
机构
[1] Natl Canc Ctr, Res Inst, Canc Prevent Div, Chuo Ku, Tokyo 104, Japan
[2] Sawai Pharmaceut Co Ltd, Osaka Res Lab, Asahi Ku, Osaka 535, Japan
[3] Hisamitsu Pharmaceut Co Inc, Tosu Res Lab, Tosu, Saga 841, Japan
[4] Japan Food Res Labs, Tama Lab, Tokyo 206, Japan
关键词
D O I
10.1093/carcin/19.11.1939
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effects of nimesulide, a selective inhibitor of cyclo-oxygenase-2 (COX-2) on azoxymethane (AOM)-induced colon carcinogenesis were investigated in mice. AOM at a dose of 10 mg/kg body wt was administered to male ICR mice once a week for 6 weeks. The animals were fed on AIN-76A powder diet containing nimesulide at doses of 200 or 400 p.p.m,, starting the day before the first carcinogen treatment until the end of the experiment, at week 30. Administration of nimesulide reduced the incidence of colon carcinomas to 32 and 25% for the AOM + 200 and 400 p.p.m. nimesulide groups, respectively, compared with the AOM + basal diet group (50%), Multiplicities of colon carcinomas in the 200 and 400 p.p.m. nimesulide-treated groups were 0.70 +/- 0.28 and 0.35 +/- 0.11, respectively, being significantly smaller than the AOM alone value (1.79 +/- 0.47), The sizes of the colon carcinomas in the nimesulide-treated groups were also decreased. No significant influence on liver and lung tumor development was apparent. Thus, nimesulide exerted a suppressive effect on AOM-induced colon carcinogenesis in mice.
引用
收藏
页码:1939 / 1942
页数:4
相关论文
共 32 条
  • [1] BOETTCHER I, 1987, DRUGS EXP CLIN RES, V13, P237
  • [2] Boolbol SK, 1996, CANCER RES, V56, P2556
  • [3] PERSPECTIVES ON CANCER IN JAPAN AND THE UNITED-STATES
    BRODER, S
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (08): : 821 - 830
  • [4] CIPOLLINI F, 1989, CURR THER RES CLIN E, V45, P1042
  • [5] Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors
    DuBois, RN
    Radhika, A
    Reddy, BS
    Entingh, AJ
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : 1259 - 1262
  • [6] UP-REGULATION OF CYCLOOXYGENASE-2 GENE-EXPRESSION IN HUMAN COLORECTAL ADENOMAS AND ADENOCARCINOMAS
    EBERHART, CE
    COFFEY, RJ
    RADHIKA, A
    GIARDIELLO, FM
    FERRENBACH, S
    DUBOIS, RN
    [J]. GASTROENTEROLOGY, 1994, 107 (04) : 1183 - 1188
  • [7] NS-398, A NEW ANTIINFLAMMATORY AGENT, SELECTIVELY INHIBITS PROSTAGLANDIN-G/H SYNTHASE CYCLOOXYGENASE (COX-2) ACTIVITY IN-VITRO
    FUTAKI, N
    TAKAHASHI, S
    YOKOYAMA, M
    ARAI, I
    HIGUCHI, S
    OTOMO, S
    [J]. PROSTAGLANDINS, 1994, 47 (01): : 55 - 59
  • [8] TREATMENT OF COLONIC AND RECTAL ADENOMAS WITH SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS
    GIARDIELLO, FM
    HAMILTON, SR
    KRUSH, AJ
    PIANTADOSI, S
    HYLIND, LM
    CELANO, P
    BOOKER, SV
    ROBINSON, CR
    OFFERHAUS, GJA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) : 1313 - 1316
  • [9] Prostaglandin synthase 2
    Herschman, HR
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (01): : 125 - 140
  • [10] Jacoby RF, 1996, CANCER RES, V56, P710